Safety and Efficacy Study of Sorbitol With Neoadjuvant Chemotherapy Combined With Tirellizumab (PD-1 Inhibitor) in Patients With Locally Advanced Gastric Cancer

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Gastric Junction Adenocarcinoma · Gastric Cancer · Immunotherapy · Neoadjuvant Therapies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Study coordinator (Kaixiong Tao, Pro.) · kaixiongtao@hust.edu.com · 86+13294158510

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma

Gastric or Esophagogastric Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study

Gastric Cancer Stage IV · Peritoneal Metastases From Gastric Cancer · Gastric or Esophagogastric Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Efficacy and Safety of Anti-PD-1, Thymalfasin, and SOX in Neoadjuvant Treatment of cStage III Gastric/Gastroesophageal Junction Adenocarcinoma

Gastric Cancer · Esophagogastric Junction Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Nanjing, China

Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC

Gastric Cancer

Abroad (travel likely)RecruitingPHASE3

Beijing, China